Febuxostat.

CAS: 144060-53-7.

99% HPLC.

Febuxostat is a novel non purine selective inhibitor of xanthine oxidase currently being developed for the management of hyperuricemia in patients with gout.

Febuxostat Was Approved By The European Medicines Agency On April 21, 2008.

Febuxostat is expected to be safer and more effective than allopurinol.

Related Searches: wholesale drugs, medications, febuxostat medicines

Please quote eSources UK when contacting us.